Tested Applications
| Positive WB detected in | Jurkat cells, HeLa cells, mouse trachea tissue, HT-29 cells, THP-1 cells |
| Positive IHC detected in | human lung cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | A549 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:5000 |
| Immunohistochemistry (IHC) | IHC : 1:100-1:400 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
14560-1-AP targets DHRS9 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag6116 Product name: Recombinant human DHRS9 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-319 aa of BC058883 Sequence: MLFWVLGLLILCGFLWTRKGKLKIEDITDKYIFITGCDSGFGNLAARTFDKKGFHVIAACLTESGSTALKAETSERLRTVLLDVTDPENVKRTAQWVKNQVGEKGLWGLINNAGVPGVLAPTDWLTLEDYREPIEVNLFGLISVTLNMLPLVKKAQGRVINVSSVGGRLAIVGGGYTPSKYAVEGFNDSLRRDMKAFGVHVSCIEPGLFKTNLADPVKVIEKKLAIWEQLSPDIKQQYGEGYIEKSLDKLKGNKSYVNMDLSPVVECMDHALTSLFPKTHYAAGKDAKIFWIPLSHMPAALQDFLLLKQKAELANPKAV Predict reactive species |
| Full Name | dehydrogenase/reductase (SDR family) member 9 |
| Calculated Molecular Weight | 35 kDa |
| Observed Molecular Weight | 45-50 kDa |
| GenBank Accession Number | BC058883 |
| Gene Symbol | DHRS9 |
| Gene ID (NCBI) | 10170 |
| RRID | AB_2277277 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9BPW9 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Dehydrogenase/reductase 9(DHRS9), is a member of the short-chain dehydrogenases/reductases (SDR) family. DHRS9 has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. DHRS9 has 4 isoforms with molecular weight of 19, 30, 35, 42 kDa, and demonstrates oxidoreductase activity toward hydroxysteroids. DHRS9 is able to convert 3-alpha-tetrahydroprogesterone to dihydroxyprogesterone and 3-alpha-androstanediol to dihydroxyprogesterone in the cytoplasm, and may additionally function as a transcriptional repressor in the nucleus.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for DHRS9 antibody 14560-1-AP | Download protocol |
| IHC protocol for DHRS9 antibody 14560-1-AP | Download protocol |
| WB protocol for DHRS9 antibody 14560-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The DHRS9 Polyclonal antibody (catalog number 14560-1-AP) has 4 total citations. These appear in EPMA Journal, Molecular Oncology, Frontiers in Molecular Biosciences, and European Journal of Psychotraumatology. The associated research fields include atherosclerosis (predictive and personalized medicine), colorectal carcinoma brain metastases, chronic obstructive pulmonary disease (emphysematous phenotype), and major depressive disorder (immune-related biomarkers). Applications span WB, IF, and IHC across human, mouse, and rat samples.
| Species | Application | Title |
|---|---|---|
EPMA J Identifying potential signatures for atherosclerosis in the context of predictive, preventive, and personalized medicine using integrative bioinformatics approaches and machine-learning strategies | ||
Mol Oncol Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival | ||
Front Mol Biosci Identification of Proteomic Signatures in Chronic Obstructive Pulmonary Disease Emphysematous Phenotype. | ||
Eur J Psychotraumatol Immune-related biomarkers for major depressive disorder identified via integrated bioinformatics and machine learning. |













